Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and ...
Score will leverage Asimov’s CHO Edge system to accelerate the development of enhanced cancer immunotherapies with improved ADCC activityBOSTON, March 17, 2026 (GLOBE NEWSWIRE) -- Asimov, the ...
EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...
Chinese Hamster Ovary (CHO) cells have been the industrial workhorse for production of biopharmaceuticals since the 1980s, with the first CHO-derived product approved by the FDA in 1987. Nearly five ...
Advances in cell line engineering and microfluidic technologies offer substantial opportunities to shorten timelines in cell line development (CLD). However, as with any innovation, optimizing these ...
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results